🐜
|
Clinical and metabolic effects associated with weight changes and obeticholic acid in non‐alcoholic steatohepatitis
99 auth.
B. Hameed,
N. Terrault,
R. Gill,
R. Loomba,
N. Chalasani,
J. Hoofnagle,
M. V. Van Natta,
D. Allende,
S. Dasarathy,
Arthur J. McCullough,
R. Penumatsa,
Jaividhya Dasarathy,
Joel E. Lavine,
Manal F. Abdelmalek,
M. Bashir,
...
S. Buie,
Anna Mae Diehl,
C. Guy,
Christopher J. N. Kigongo,
Mariko F Kopping,
David Malik,
Dawn L. Piercy,
N. Chalasani,
Oscar W. Cummings,
S. Gawrieh,
L. Ragozzino,
K. Sandrasegaran,
R. Vuppalanchi,
Elizabeth M. Brunt,
T. Cattoor,
Danielle H. Carpenter,
Janet Freebersyser,
D. King,
J. Lai,
Brent A. Neuschwander‐Tetri,
Joan Siegner,
S. Stewart,
S. Torretta,
Kristina Wriston,
Maria Cardona Gonzalez,
Jodie Davila,
Manan A. Jhaveri,
Kris V. Kowdley,
N. Mukhtar,
E. Ness,
Michelle Poitevin,
Brook A Quist,
Sherilynn Soo,
Brandon Ang,
Cynthia E. Behling,
A. Bhatt,
R. Loomba,
Michael S. Middleton,
C. Sirlin,
Maheen F. Akhter,
Nathan M. Bass,
Danielle Brandman,
R. Gill,
B. Hameed,
J. Maher,
N. Terrault,
A. Ungermann,
M. Yeh,
Sherry L Boyett,
Melissa J. Contos,
Sherri Kirwin,
Velimir AC Luketic,
P. Puri,
Arun J. Sanyal,
Jolene Schlosser,
Mohammad S. Siddiqui,
Leslie Yost‐Schomer,
Kathryn J Fowler,
David E. Kleiner,
Edward C. Doo,
S. Hall,
Jay H. Hoofnagle,
Jessica J. Lee,
Patricia R. Robuck,
Averell H. Sherker,
R. Torrance,
Patricia H. Belt,
Jeanne M. Clark,
J. Dodge,
M. Donithan,
E. Hallinan,
M. Isaacson,
M. Lazo,
Jill Meinert,
L. Miriel,
Jacqueline Smith,
Michael Smith,
Alice Sternberg,
J. Tonascia,
Mark L. Van Natta,
Annette Wagoner,
Laura A. Wilson,
Goro Yamada,
Katherine P. Yates
|
5 |
2018 |
5 🐜
|
🐜
|
NAFLD: Reporting Histologic Findings in Clinical Practice
9 auth.
E. Brunt,
D. Kleiner,
Danielle H. Carpenter,
M. Rinella,
S. Harrison,
R. Loomba,
...
Z. Younossi,
B. Neuschwander‐Tetri,
A. Sanyal
|
5 |
2021 |
5 🐜
|
🐜
|
Glycogenosis is common in nonalcoholic fatty liver disease and is independently associated with ballooning, but lower steatosis and lower fibrosis
13 auth.
D. Allende,
S. Gawrieh,
O. Cummings,
Patricia H. Belt,
L. Wilson,
M. V. Van Natta,
C. Behling,
Danielle H. Carpenter,
R. Gill,
D. Kleiner,
...
M. M. Yeh,
N. Chalasani,
C. Guy
|
4 |
2020 |
4 🐜
|
🐜
|
PPARα Agonist Fenofibrate Attenuates Iron Induced Liver Injury in Mice by Modulating the Sirt3 and β-catenin Signaling.
10 auth.
Ashok Mandala,
William J Chen,
Austin Armstrong,
Mila Malhotra,
Sanmathi Chavalmane,
K. McCommis,
...
Anping Chen,
Danielle H. Carpenter,
P. Biswas,
Jaya P. Gnana-Prakasam
|
4 |
2021 |
4 🐜
|
🐜
|
Enhancing Hepatic MBOAT7 Expression in Mice With Nonalcoholic Steatohepatitis
12 auth.
Martin C. Sharpe,
Kelly D. Pyles,
Taylor Hallcox,
Dakota R. Kamm,
M. Piechowski,
Bryan Fisk,
...
Carolyn J. Albert,
Danielle H. Carpenter,
B. Ulmasov,
D. Ford,
B. Neuschwander‐Tetri,
K. McCommis
|
3 |
2023 |
3 🐜
|
🐜
|
Adipose-targeted SWELL1 deletion exacerbates obesity- and age-related nonalcoholic fatty liver disease
8 auth.
Susheel K. Gunasekar,
John Heebink,
Danielle H. Carpenter,
Ashutosh Kumar,
Litao Xie,
Haixia Zhang,
...
J. Schilling,
R. Sah
|
2 |
2023 |
2 🐜
|
🐜
|
The IP6K Inhibitor LI-2242 Ameliorates Diet-Induced Obesity, Hyperglycemia, and Hepatic Steatosis in Mice by Improving Cell Metabolism and Insulin Signaling
8 auth.
Sandip Mukherjee,
M. Chakraborty,
Jake Haubner,
Glen E Ernst,
M. Depasquale,
Danielle H. Carpenter,
...
J. Barrow,
A. Chakraborty
|
2 |
2023 |
2 🐜
|